Interleukin 1 and Bone Resorption in Squamous Carcinoma
Author Information
Author(s): S. Meghji, J.R. Sandy, A.M. Scutt, W. Harvey, R.L. Carter, M. Harris
Primary Institution: Institute of Cancer Research, Royal Marsden Hospital
Hypothesis
Does interleukin 1 contribute to the bone resorbing activity synthesized by squamous carcinoma cells in vitro?
Conclusion
The study found that interleukin 1 is responsible for the bone resorbing activity produced by squamous carcinoma cell lines.
Supporting Evidence
- All three cell lines produced significant bone resorption activity.
- Bone resorbing activity was abolished by adding anti-human IL1 antibody.
- IL1-like activity was confirmed through various bioassays.
Takeaway
This study shows that a substance called interleukin 1 helps cancer cells break down bone, which can be a problem for people with certain types of cancer.
Methodology
The study used three human squamous carcinoma cell lines to investigate their bone-resorbing activity in vitro through various assays.
Participant Demographics
Cell lines derived from squamous cell carcinomas of the head and neck.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website